Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_assertion type Assertion NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_head.
- NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_assertion description "[Antipsychotics and serotoninergic antidepressants may potentially attenuate PD risk, and lithium and bupropion may augment risk, through MAPT, GBA, CCDC62, HIP1R, BDNF, and DRD2 transcription, with MAPT, GBA, and CCDC62 being strongly associated with PD risk in recent meta-analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_provenance.
- NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_assertion evidence source_evidence_literature NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_provenance.
- NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_assertion SIO_000772 22507762 NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_provenance.
- NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_assertion wasDerivedFrom befree-20140225 NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_provenance.
- NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_assertion wasGeneratedBy ECO_0000203 NP332958.RAJk2BvHeF2vK5Iq8fREUJvXAb6XdChPNKqwrD_S4xy5E130_provenance.